{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:02:34Z","timestamp":1789754554606,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"CONAHCYT","doi-asserted-by":"publisher","award":["2014\\u20131-233647"],"award-info":[{"award-number":["2014\\u20131-233647"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.radonc.2026.111483","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:23:10Z","timestamp":1773332590000},"page":"111483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Long\u2011term outcomes of prophylactic cranial irradiation in high\u2011risk metastatic NSCLC: Final PRoT\u2011BM analysis"],"prefix":"10.1016","volume":"219","author":[{"given":"Luis","family":"Cabrera-Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2422-1671","authenticated-orcid":false,"given":"Eduardo","family":"Rios-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny G.","family":"Turcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Caball\u00e9-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Reynoso-Noveron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6228-1800","authenticated-orcid":false,"given":"Pamela","family":"Soberanis-Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Blake-Cerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7443-4627","authenticated-orcid":false,"given":"Francisco","family":"Lozano-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Beato-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Cacho-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s F.","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1164-3779","authenticated-orcid":false,"given":"Oscar","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111483_b0005","doi-asserted-by":"crossref","unstructured":"Parker M, Jiang K, Rincon-Torroella J, Materi J, Azad TD, Kamson DO, et al. Epidemiological trends, prognostic factors, and survival outcomes of synchronous brain metastases from 2015 to 2019: a population-based study. Neurooncol Adv. 2023;5:vdad015.","DOI":"10.1093\/noajnl\/vdad015"},{"key":"10.1016\/j.radonc.2026.111483_b0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.2015.62.0138","article-title":"Extended Survival and Prognostic Factors for patients with ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis","volume":"34","author":"Johung","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lungcan.2015.01.020","article-title":"Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers","volume":"88","author":"Rangachari","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111483_b0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ctrv.2016.03.009","article-title":"The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer","volume":"45","author":"Peters","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2026.111483_b0025","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.21037\/atm.2019.04.04","article-title":"Brain metastases in EGFR-positive non-small cell lung cancer: the way to the sanctuary becomes less winding","volume":"7","author":"Passaro","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.radonc.2026.111483_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032242","article-title":"Comparative Efficacy of ALK Inhibitors for Treatment-Naive ALK-Positive Advanced Non-Small Cell Lung Cancer with Central nervous System Metastasis: a Network Meta-Analysis","volume":"24","author":"Ando","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111483_b0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4143\/crt.2022.078","article-title":"Challenges in the use of Targeted Therapies in Non-Small Cell Lung Cancer","volume":"54","author":"Rivera-Concepcion","year":"2022","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.radonc.2026.111483_b0040","doi-asserted-by":"crossref","DOI":"10.1177\/10732748231189785","article-title":"Survival Outcomes of Metastatic Non-small Cell Lung Cancer patients with Limited Access to Immunotherapy and Targeted Therapy in a Cancer Center of a Low- and Middle-Income Country","volume":"30","author":"Ballen","year":"2023","journal-title":"Cancer Control"},{"key":"10.1016\/j.radonc.2026.111483_b0045","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jamaoncol.2018.7220","article-title":"Prophylactic Cranial Irradiation vs Observation in patients with locally Advanced Non-Small Cell Lung Cancer: a long-term Update of the NRG Oncology\/RTOG 0214 phase 3 Randomized Clinical Trial","volume":"5","author":"Sun","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0050","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1200\/JCO.2017.77.5817","article-title":"Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: a Randomized phase III NVALT-11\/DLCRG-02 Study","volume":"36","author":"De Ruysscher","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lungcan.2015.01.020","article-title":"Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers","volume":"88","author":"Rangachari","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111483_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102807","article-title":"Central nervous system metastases in advanced non-small cell lung cancer: a review of the therapeutic landscape","volume":"130","author":"Weller","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2026.111483_b0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cllc.2024.06.004","article-title":"The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases","volume":"25","author":"Wu","year":"2024","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111483_b0070","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2021.02.044","article-title":"Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer patients: a Randomized phase 2 Study (PRoT-BM trial)","volume":"110","author":"Arrieta","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111483_b0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijrobp.2021.04.017","article-title":"Prophylactic Cranial Irradiation in patients with High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized phase II Study","volume":"111","author":"Maldonado","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111483_b0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2021.02.002","article-title":"Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer","volume":"158","author":"Witlox","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fonc.2020.00011","article-title":"The Role of Prophylactic Cranial Irradiation in patients with Non-small Cell Lung Cancer: an Updated Systematic Review and Meta-Analysis","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fonc.2018.00115","article-title":"Prophylactic Cranial Irradiation in patients with Non-Small-Cell Lung Cancer: a Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"8","author":"Al Feghali","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0095","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal Metastases in patients with NSCLC with EGFR Mutations","volume":"11","author":"Li","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2018.11.022","article-title":"Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer","volume":"127","author":"Wu","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111483_b0105","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3171\/2022.8.JNS221175","article-title":"Multidisciplinary management of patients with non-small cell lung cancer with leptomeningeal metastasis in the tyrosine kinase inhibitor era","volume":"138","author":"Chen","year":"2023","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2026.111483_b0110","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): a GICOR-GOECP-SEOR Study","volume":"39","author":"Rodriguez de Dios","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0115","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.78.3118","article-title":"CNS Response to Osimertinib Versus Standard Epidermal Growth factor Receptor Tyrosine Kinase Inhibitors in patients with Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer","author":"Reungwetwattana","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0120","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa2306434","article-title":"Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC","volume":"389","author":"Planchard","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111483_b0125","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.24.00581","article-title":"Lorlatinib Versus Crizotinib in patients with Advanced ALK-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes from the phase III CROWN Study","author":"Solomon","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jtho.2021.08.009","article-title":"Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination with Radiation","volume":"17","author":"Thomas","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0135","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/ijc.33904","article-title":"Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasis","volume":"150","author":"Zhao","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2026.111483_b0140","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ijrobp.2021.05.125","article-title":"Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth factor Receptor-Mutant Non-Small Cell Lung Cancer with Brain Metastases","volume":"111","author":"Yu","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111483_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2025.01.004","article-title":"Elucidating the Role of EGFRL858R in Brain Metastasis among patients with Advanced NSCLC Undergoing TKI Therapy","author":"Rios-Garcia","year":"2025","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111483_b0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jtho.2023.08.007","article-title":"Impact of concurrent Genomic Alterations on Clinical Outcomes in patients with ALK-Rearranged NSCLC","volume":"19","author":"Lara-Mejia","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010307","article-title":"A \u201cSeed-and-Soil\u201d Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation","volume":"15","author":"Chu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2026.111483_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274876","article-title":"Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: a retrospective cohort study using nationwide claims data","volume":"17","author":"Shim","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2026.111483_b0165","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s00262-022-03224-2","article-title":"Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis","volume":"71","author":"Chen","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.radonc.2026.111483_b0170","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/neuonc\/noaa092","article-title":"Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer","volume":"22","author":"Westover","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2026.111483_b0175","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/s41591-025-03577-y","article-title":"Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer","volume":"31","author":"Herbst","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2026.111483_b0180","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1038\/s41598-025-88266-z","article-title":"Long-term survival and undetectable circulating tumor DNA following comprehensive involved site radiotherapy for oligometastases","volume":"15","author":"Radigan","year":"2025","journal-title":"Sci Rep"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026001222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026001222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:05:48Z","timestamp":1789751148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026001222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"alternative-id":["S0167814026001222"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111483","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long\u2011term outcomes of prophylactic cranial irradiation in high\u2011risk metastatic NSCLC: Final PRoT\u2011BM analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111483"}}